AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MANHATTAN CORP LTD

0.025

0.000

Volume:100.00K

Turnover:2.50K

Market Cap:13.93M

PE:-5.69

High:0.025

Open:0.025

Low:0.025

Close:0.025

52wk High:0.037

52wk Low:0.016

Shares:557.37M

Float Shares:335.50M

Volume Ratio:0.05

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.004

EPS(LYR):-0.004

ROE:-7.29%

ROA:-4.16%

PB:1.07

PE(LYR):-5.69

Loading ...

Overview Company News Filings

Non-Executive Director of Manhattan Gavin Rezos Buys 20% More Shares

Simply Wall St.

Everest Medicines Announces First Patient Dosed in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14

BUZZ-Australia's Manhattan Corp gains on gold find at Canadian site

Manhattan Corp Ltd-Proposed Issue of Securities - Mhc

THOMSON REUTERS

Manhattan Corp Ltd-Updated Securities Trading Policy

THOMSON REUTERS

Manhattan Corp Ltd-Corporate and Hook Lake Project Update

THOMSON REUTERS

Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14

Everest Medicines Announces NMPA Approval of IND Application for Tumor-Associated Antigen Cancer Vaccine EVM14

Manhattan Expands Canada Gold Project Exploration Footprint

MT Newswires Live

BRIEF-Manhattan Announces A$2.2 Million Placement To Advance Hook Lake Project At A$0.02 Per Share

Manhattan - a2.2 Mln Placement to Advance Hook Lake Project at a$0.02 per Share

THOMSON REUTERS

BRIEF-Manhattan Corp Seeks Trading Halt

Manhattan Corp Ltd-Completion of High Grade Gold and Copper Acquisition

THOMSON REUTERS

ASX ALERT-Novo announces Drilling Results at Tibooburra Gold Project,MHC-NVO.TO

Notice of July 2025 General Meeting-MHC.AX

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MHC.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MHC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MHC.AU\",,,,,undefined,":{"symbol":"MHC.AU","market":"AU","secType":"STK","nameCN":"MANHATTAN CORP LTD","latestPrice":0.025,"timestamp":1765516320000,"preClose":0.025,"halted":0,"volume":100000,"delay":0,"nameEN":"MANHATTAN CORP LTD","floatShares":335498120,"shares":557373622,"eps":-0.004397,"marketStatus":"Not Yet Opened","change":0,"latestTime":"12-12 16:12:00 AEDT","open":0.025,"high":0.025,"low":0.025,"amount":2500,"amplitude":0,"askPrice":0.03,"askSize":584670,"bidPrice":0.025,"bidSize":272490,"shortable":3,"etf":0,"ttmEps":-0.004397,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1765753200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.025,"openAndCloseTimeList":[[1765494000000,1765515600000]],"volumeRatio":0.04505834740661831,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MHC.AU\",,,,,undefined,":{"symbol":"MHC.AU","floatShares":335498120,"roa":"-4.16%","roe":"-7.29%","lyrEps":-0.004397,"volumeRatio":0.04505834740661831,"shares":557373622,"dividePrice":0,"high":0.025,"amplitude":0,"preClose":0.025,"low":0.025,"week52Low":0.016,"pbRate":"1.07","psRate":"685.44","week52High":0.037,"institutionHeld":0,"latestPrice":0.025,"committee":-0.364203,"eps":-0.004397,"divideRate":0,"volume":100000,"delay":0,"ttmEps":-0.004397,"open":0.025,"prevYearClose":0.019,"prevWeekClose":0.026,"prevMonthClose":0.023,"prevQuarterClose":0.023,"fiveDayClose":0.026,"twentyDayClose":0.026,"sixtyDayClose":0.022,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MHC.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-12-04","symbol":"MHC.AU","type":"split","dateTimestamp":1733230800000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MHC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MHC.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589584844","title":"Non-Executive Director of Manhattan Gavin Rezos Buys 20% More Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589584844","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589584844?lang=en_us&edition=fundamental","pubTime":"2025-12-06 04:23","pubTimestamp":1764966222,"startTime":"0","endTime":"0","summary":"Investors who take an interest in Manhattan Corporation Limited ( ASX:MHC ) should definitely note that the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052001-choice1-main-header/1585186931882","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052001-choice1-main-header/1585186931882"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-mhc/manhattan-shares/news/non-executive-director-of-manhattan-gavin-rezos-buys-20-more","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-mhc/manhattan-shares/news/non-executive-director-of-manhattan-gavin-rezos-buys-20-more","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7104","MHC.AU"],"gpt_icon":0},{"id":"2585195362","title":"Everest Medicines Announces First Patient Dosed in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14","url":"https://stock-news.laohu8.com/highlight/detail?id=2585195362","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585195362?lang=en_us&edition=fundamental","pubTime":"2025-11-21 12:01","pubTimestamp":1763697660,"startTime":"0","endTime":"0","summary":"The first patient had received the first dose of EVM14 injection in a global, multi-center Phase I clinical trial of Everest Medicines' Tumor-Associated Antigen  Cancer Vaccine EVM14 at NEXT Oncology Virginia in the United States, marking an important milestone in its global clinical development.The primary endpoints of the EVM14 Phase I trial are safety and tolerability, with secondary endpoints evaluating preliminary efficacy. EVM14 is Everest Medicines' first internally developed therapeutic mRNA cancer vaccine to obtain IND approvals from both China National Medical Products Administration  and the U.S. Food and Drug Administration .The EVM14 Phase I trial is a dose-escalation study with two cohorts: EVM14 monotherapy and EVM14 in combination with PD-1 monoclonal antibody. The trial enrolls patients with pathologically confirmed unresectable, advanced, recurrent, or metastatic squamous non-small cell lung cancer  and head and neck squamous cell carcinoma , who have experienced dise","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/everest-medicines-announces-first-patient-dosed-in-a-global-multi-center-phase-i-clinical-trial-of-tumor-associated-antigen-cancer-vaccine-evm14-302622741.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHC.AU","BK7104","MDCO"],"gpt_icon":0},{"id":"2583532818","title":"BUZZ-Australia's Manhattan Corp gains on gold find at Canadian site","url":"https://stock-news.laohu8.com/highlight/detail?id=2583532818","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583532818?lang=en_us&edition=fundamental","pubTime":"2025-11-13 12:55","pubTimestamp":1763009750,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Manhattan Corp gains on gold find at Canadian site** Shares of Manhattan Corp MHC.AX rise as much as 16% to A$0.029, posting their biggest intraday pct gain since July 23 ** Stock hits its highest level since November 3** Mineral explorer finds high-grade gold from wider regional targets at Hook Lake project in Canada** About 3.9 mln shares change hands, 3.7x the 30-day average** YTD, stock up 42.1%, including current session's move  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL6N3WP09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHC.AU","BK7104"],"gpt_icon":0},{"id":"2579941921","title":"Manhattan Corp Ltd-Proposed Issue of Securities - Mhc","url":"https://stock-news.laohu8.com/highlight/detail?id=2579941921","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579941921?lang=en_us&edition=fundamental","pubTime":"2025-10-29 15:55","pubTimestamp":1761724507,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUE75NR4F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MHC.AU","BK7104"],"gpt_icon":0},{"id":"2576670068","title":"Manhattan Corp Ltd-Updated Securities Trading Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2576670068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576670068?lang=en_us&edition=fundamental","pubTime":"2025-10-17 13:13","pubTimestamp":1760678022,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nTUE91FMXL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MHC.AU","BK7104"],"gpt_icon":0},{"id":"2575750385","title":"Manhattan Corp Ltd-Corporate and Hook Lake Project Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2575750385","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575750385?lang=en_us&edition=fundamental","pubTime":"2025-10-16 06:38","pubTimestamp":1760567932,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nTUE6NTZWK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7104","MHC.AU"],"gpt_icon":0},{"id":"2575257682","title":"Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14","url":"https://stock-news.laohu8.com/highlight/detail?id=2575257682","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575257682?lang=en_us&edition=fundamental","pubTime":"2025-10-14 12:13","pubTimestamp":1760415180,"startTime":"0","endTime":"0","summary":"SHANGHAI, Oct. 14, 2025 /PRNewswire/ -- Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that the first patient has been enrolled in a global multi-center Phase I clinical trial of its Tumor-Associated Antigen Cancer Vaccine EVM14 at NEXT Oncology Virginia in the United States. This marks an important clinical achievement following EVM14's Investigational New Drug  approvals by both the U.S. Food and Drug Administration  and China's National Medical Products Administration .In preclinical studies, EVM14 induced a dose-dependent antigen-specific immune response in mice and significantly inhibited tumor growth in multiple syngeneic tumor models. Notably, EVM14 demonstrated the ability to induce immune memory and prevent tumor recurrence, offering hope for long-term cancer-free survival. Furthermore, preclinical data demonstrated that the combination of EVM14 wit","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/everest-medicines-announces-first-patient-enrolled-in-a-global-multi-center-phase-i-clinical-trial-of-tumor-associated-antigen-cancer-vaccine-evm14-302582820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCO","IND.AU","BK7095","MHC.AU","BK7104"],"gpt_icon":0},{"id":"2575182442","title":"Everest Medicines Announces NMPA Approval of IND Application for Tumor-Associated Antigen Cancer Vaccine EVM14","url":"https://stock-news.laohu8.com/highlight/detail?id=2575182442","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575182442?lang=en_us&edition=fundamental","pubTime":"2025-10-13 08:47","pubTimestamp":1760316420,"startTime":"0","endTime":"0","summary":"EVM14, an off-the-shelf therapeuticmRNA cancer vaccine, is developed based on Everest Medicines' proprietary mRNA platform. It is formulated with mRNA encoding 5 tumor-associated antigens  and is designed to treat various squamous cell carcinomas.In preclinical studies, EVM14 demonstrated the ability to induce immune memory and prevent tumor recurrence, offering hope for long-term cancer-free survival.\"The cancer burden in China remains substantial. Neither immunotherapy nor targeted therapy can offer long term benefits to cancer patients. As a tumor-associated antigen cancer vaccine, EVM14is designed to treat various squamous cell carcinomas,\" Professor Lu Shun, the Lead Principal Investigator in China and Director of the Oncology Department at Shanghai Chest Hospital, stated: \" EVM14's unique mechanism offers the potential to complement current treatments by enhancing the efficacy via combination therapies and helping delay disease recurrence, aligning with current trends in oncology","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/everest-medicines-announces-nmpa-approval-of-ind-application-for-tumor-associated-antigen-cancer-vaccine-evm14-302581546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND.AU","BK7104","MHC.AU","BK7095","MDCO"],"gpt_icon":0},{"id":"2570050651","title":"Manhattan Expands Canada Gold Project Exploration Footprint","url":"https://stock-news.laohu8.com/highlight/detail?id=2570050651","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570050651?lang=en_us&edition=fundamental","pubTime":"2025-09-25 13:40","pubTimestamp":1758778822,"startTime":"0","endTime":"0","summary":"Manhattan  expanded the exploration footprint of the Hook Lake gold project in Canada after staking new mineral claims totaling 70.7 square kilometers, according to a Thursday Australian bourse filing.The firm has an application in process to expand an exploration agreement with the Nunavut Tunngavik.A high-resolution magnetic survey is scheduled to begin imminently, covering the recently expanded exploration portfolio, targeting all styles of gold and polymetallic mineralization within the project.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7104","1OZmain","MHC.AU"],"gpt_icon":0},{"id":"2555702726","title":"BRIEF-Manhattan Announces A$2.2 Million Placement To Advance Hook Lake Project At A$0.02 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2555702726","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555702726?lang=en_us&edition=fundamental","pubTime":"2025-07-29 07:49","pubTimestamp":1753746588,"startTime":"0","endTime":"0","summary":"BRIEF-Manhattan Announces A$2.2 Million Placement To Advance Hook Lake Project At A$0.02 Per ShareJuly 29 (Reuters) - Manhattan Corp Ltd MHC.AX:A$2.2 MILLION PLACEMENT TO ADVANCE HOOK LAKE PROJECT AT A$0.02 PER SHAREFurther company coverage: MHC.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nL8N3TP2E4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7104","MHC.AU"],"gpt_icon":0},{"id":"2555702796","title":"Manhattan -  a2.2 Mln Placement to Advance Hook Lake Project at a$0.02 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2555702796","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555702796?lang=en_us&edition=fundamental","pubTime":"2025-07-29 07:47","pubTimestamp":1753746447,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nFWN3TP28Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MHC.AU","BK7104"],"gpt_icon":0},{"id":"2554451736","title":"BRIEF-Manhattan Corp Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2554451736","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554451736?lang=en_us&edition=fundamental","pubTime":"2025-07-25 07:05","pubTimestamp":1753398335,"startTime":"0","endTime":"0","summary":"BRIEF-Manhattan Corp Seeks Trading HaltJuly 25 (Reuters) - Manhattan Corp Ltd MHC.AX:TRADING HALT REQUESTED PENDING CAPITAL RAISING ANNOUNCEMENTFurther company coverage: MHC.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nFWN3TL1JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7104","MHC.AU"],"gpt_icon":0},{"id":"2553277793","title":"Manhattan Corp Ltd-Completion of High Grade Gold and Copper Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2553277793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553277793?lang=en_us&edition=fundamental","pubTime":"2025-07-24 16:29","pubTimestamp":1753345765,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nTUE4PRF30:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MHC.AU","BK7104"],"gpt_icon":0},{"id":"2550576473","title":"ASX ALERT-Novo announces Drilling Results at Tibooburra Gold Project,MHC-NVO.TO","url":"https://stock-news.laohu8.com/highlight/detail?id=2550576473","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550576473?lang=en_us&edition=fundamental","pubTime":"2025-07-09 06:20","pubTimestamp":1752013221,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250708:nASX2k2p1F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nASX2M3hCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","KSN.AU","MHC.AU","BK7104"],"gpt_icon":0},{"id":"2545676456","title":"Notice of July 2025 General Meeting-MHC.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2545676456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545676456?lang=en_us&edition=fundamental","pubTime":"2025-06-23 06:18","pubTimestamp":1750630693,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250622:nASX3bwH5f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250622:nASX8vLCD7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7104","MHC.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}